Post Categories
Blog post not found!
Back in Black: Understanding the Origins of the “Original Pandemic”
July 21, 2022
In a time when news headlines, academic journals, and science websites sharing the latest discoveries and theories about SARS-CoV-2 and its many variants demand…
Changing Our Perspective on “Mind-Altering” Drugs – Part II
July 19, 2022
Developing an effective and safe medicine is a labor of love in any therapeutic area, but perhaps none so much as the central nervous…
Brain Implant Enables Communication in ALS Patient
June 29, 2022
As many as 30,000 people in the United States are currently diagnosed with amyotrophic lateral sclerosis, or ALS. This debilitating neurological condition is caused…
Changing Our Perspective on “Mind-Altering” Drugs – Part I
June 28, 2022
For a generation that grew up with “Just Say No” as a recurring theme, the idea of taking psychedelics with nicknames such as acid…
New Obesity Drug Shows Great Promise in Phase III Trials
June 22, 2022
Danish pharmaceutical giant Novo Nordisk changed the game last year, presenting data that suggested one of the company’s diabetes drugs was also highly effective…
Could a New Gap-Free Human Genome Make Personal DNA Sequencing “Routine” Care?
June 20, 2022
In 2003, while recognizing the 50th anniversary of the discovery of the double helix, researchers announced that the human genome had been sequenced —…
Introduction Antiviral drugs play a central role in treating viral infections, reducing disease progression and preparing for future outbreaks. While vaccines can help prevent…
Executive Summary The boundary between pharmacovigilance and regulatory affairs has never been thinner. As health authorities accelerate the digitization of safety reporting, tighten electronic…
Executive Summary Biosimilars have advanced from a promising idea to a proven pathway for expanding patient access to biologic therapies and easing pressure on…
NEWARK, Del.–(BUSINESS WIRE)–QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials announces the successful implementation of Oracle…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…